Targeted restoration of down-regulated DAPK2 tumor suppressor activity induces apoptosis in Hodgkin lymphoma cells.
about
A human recombinant autoantibody-based immunotoxin specific for the fetal acetylcholine receptor inhibits rhabdomyosarcoma growth in vitro and in a murine transplantation model.PIAS3 activates the intrinsic apoptotic pathway in non-small cell lung cancer cells independent of p53 status.Novel myeloma-associated antigens revealed in the context of syngeneic hematopoietic stem cell transplantation.Microtubule-associated protein tau facilitates the targeted killing of proliferating cancer cells in vitro and in a xenograft mouse tumour model in vivo.The functionalized human serine protease granzyme B/VEGF₁₂₁ targets tumor vasculature and ablates tumor growth.Human toxin-based recombinant immunotoxins/chimeric proteins as a drug delivery system for targeted treatment of human diseases.Macrophage-targeted therapy: CD64-based immunotoxins for treatment of chronic inflammatory diseases.CD30 as a therapeutic target for lymphoma.The DAPK family: a structure-function analysis.How recombinant swollenin from Kluyveromyces lactis affects cellulosic substrates and accelerates their hydrolysisDAPK2 regulates oxidative stress in cancer cells by preserving mitochondrial function.DAPK2 is a novel regulator of mTORC1 activity and autophagy.Human microtubule-associated protein tau mediates targeted killing of CD30(+) lymphoma cells in vitro and inhibits tumour growth in vivo.In vivo imaging of immunotoxin treatment using Katushka-transfected A-431 cells in a murine xenograft tumour model.External Qi of Yan Xin Qigong induces cell death and gene expression alterations promoting apoptosis and inhibiting proliferation, migration and glucose metabolism in small-cell lung cancer cells.Apoptotic gene expression by human periodontal ligament cells following cyclic stretch.Fully human MAP-fusion protein selectively targets and eliminates proliferating CD64(+) M1 macrophages.Restoration of DAP Kinase Tumor Suppressor Function: A Therapeutic Strategy to Selectively Induce Apoptosis in Cancer Cells Using Immunokinase Fusion Proteins.
P2860
Q33692521-5DACFCF0-A598-4837-A864-5BC46498292AQ34352295-1D33450D-FFC2-4430-8034-563E58C3BAC1Q35877000-81CB413B-BB67-42F8-9F88-86EA77FEB7A6Q37182201-14AEB92F-DD19-4172-A18F-EA9F1ACEC81BQ37577621-CA1FDE4A-FFCF-429C-B22C-80A545167EF2Q37859775-15877E60-90DC-4BAA-BF4E-0A13E8240B3CQ38056128-39203A60-9A18-4D32-B535-332F07493634Q38138482-5B1AD7D7-37E6-483E-B462-85FDB88D8827Q38162088-FD607669-335F-4EA4-A03E-38E93AB2BC54Q38850242-EC3D71E2-FAE7-4E58-8FDD-2203F4485A2CQ38903348-BF4D1F29-9BF4-427E-A64B-1A517994FCAFQ38943500-0F9A491C-6ED4-4CDB-A2A5-9990358A1DC3Q39069677-870C2A38-BC11-460F-BFD1-F6AB72A05583Q39393492-898A7030-6376-41BE-8E67-0B00C8F1AC4BQ39429668-D107A663-2185-4B4E-BD9A-F5387B40098DQ39726380-A5254F56-77E5-4947-8AD0-A880EFE1644BQ51314320-0C3BF880-401C-41CA-9F46-7B0B23CD8849Q51793176-9D780A7B-76A2-4E8C-97DF-FFEA2AF37A37
P2860
Targeted restoration of down-regulated DAPK2 tumor suppressor activity induces apoptosis in Hodgkin lymphoma cells.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Targeted restoration of down-r ...... sis in Hodgkin lymphoma cells.
@en
Targeted restoration of down-r ...... sis in Hodgkin lymphoma cells.
@nl
type
label
Targeted restoration of down-r ...... sis in Hodgkin lymphoma cells.
@en
Targeted restoration of down-r ...... sis in Hodgkin lymphoma cells.
@nl
prefLabel
Targeted restoration of down-r ...... sis in Hodgkin lymphoma cells.
@en
Targeted restoration of down-r ...... sis in Hodgkin lymphoma cells.
@nl
P2093
P1476
Targeted restoration of down-r ...... sis in Hodgkin lymphoma cells.
@en
P2093
Edgar Jost
Gernot Jäger
Markus Ribbert
Michael Stöcker
Oliver Galm
Rainhardt Osieka
Uwe Klinge
P304
P356
10.1097/CJI.0B013E31819F1CB6
P577
2009-06-01T00:00:00Z